Mobile teledermatology helping patients control high‐need acne: a randomized controlled trial

• DOI: 10.1111/jdv.12723
• Publication Date: 2014-09-26T07:00:55Z
• Authors: J. Frühauf; S. Kröck; F. Quehenberger; D. Kopera; R. Fink‐Puches; P. Komericki; S. Pucher; E. Arzberger; R. Hofmann‐Wellenhof
• Keywords: Teledermatology; Concordance; Isotretinoin

Abstract Background Acne is an important health issue with a major psychological impact in addition to the physical problems it causes. Objectives To investigate superiority of mobile teledermatology care patients high‐need facial acne comparison outpatient services particular attention treatment efficacy, safety, and patient compliance. Further, satisfaction remote was evaluated. Methods Sixty‐nine consecutive (f: 25, m: 44, median age: 19 years, range: 13–37 years) were randomly allocated either teleconsultation ( TCA ) or consultation OCA arm trial receive isotretinoin weight severity‐dependent dosages over 24 weeks. grading performed by one examiner using Global Severity Scale GEA total lesion counting TLC ). Results Due noncompliance issues, 17 69 (24.6%) excluded from study, who 10 had been assigned (10/34; 29.4%) 7 (7/35; 20%). Both, ‐score: ∆ = 2.25; : 89.08) 2.0; 91.21) excellent almost equivalent therapeutic outcomes achieved. In , however, less experienced adverse reactions P 0.55). Even though additional live supervision would have appreciated some cases, satisfied service no request created. Conclusion Mobile efficient, safe well‐accepted tool among constituting at least valuable adjunct services. Further larger studies be useful confirm our findings.